HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stephen V Liu Selected Research

pralsetinib

1/2022Addressing challenges with real-world synthetic control arms to demonstrate the comparative effectiveness of Pralsetinib in non-small cell lung cancer.
1/2021Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stephen V Liu Research Topics

Disease

57Neoplasms (Cancer)
05/2022 - 03/2010
27Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 03/2012
17Lung Neoplasms (Lung Cancer)
01/2022 - 01/2013
13Small Cell Lung Carcinoma (Small Cell Lung Cancer)
11/2022 - 10/2016
9Disease Progression
01/2022 - 05/2017
7Prostatic Neoplasms (Prostate Cancer)
12/2017 - 09/2010
6Carcinoma (Carcinomatosis)
12/2021 - 12/2012
4Neoplasm Metastasis (Metastasis)
10/2021 - 12/2015
3COVID-19
01/2021 - 01/2020
2Adenocarcinoma of Lung
01/2022 - 06/2021
2Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 01/2017
2Hematologic Neoplasms (Hematological Malignancy)
01/2021 - 01/2016
2Central Nervous System Diseases (CNS Diseases)
01/2021 - 01/2017
2Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2020 - 12/2012
2Brain Neoplasms (Brain Tumor)
01/2019 - 01/2018
2Squamous Cell Carcinoma of Head and Neck
01/2019 - 05/2017
2Head and Neck Neoplasms (Head and Neck Cancer)
01/2019 - 05/2017
2Circulating Neoplastic Cells
12/2017 - 12/2014
2Thyroid Neoplasms (Thyroid Cancer)
10/2017 - 01/2017
2Melanoma (Melanoma, Malignant)
01/2017 - 01/2016
1ST Elevation Myocardial Infarction
01/2022
1Testicular Neoplasms (Testicular Cancer)
12/2021
1Hypoxia (Hypoxemia)
01/2021
1Nausea
12/2020
1Mucositis
12/2020
1Vomiting
12/2020
1Fatigue
12/2020
1Diarrhea
12/2020
1Hypertension (High Blood Pressure)
01/2020
1Chronic Obstructive Pulmonary Disease (COPD)
01/2020
1Mouth Neoplasms (Oral Cancer)
01/2020
1Hepatitis C
12/2019

Drug/Important Bio-Agent (IBA)

7entrectinibIBA
05/2022 - 12/2015
7Immune Checkpoint InhibitorsIBA
01/2022 - 01/2019
7pembrolizumabIBA
01/2022 - 05/2017
6Biomarkers (Surrogate Marker)IBA
01/2022 - 09/2015
5B7-H1 AntigenIBA
01/2022 - 01/2018
5Phosphotransferases (Kinase)IBA
01/2022 - 03/2014
5atezolizumabIBA
01/2021 - 01/2018
5Tyrosine Kinase InhibitorsIBA
01/2021 - 10/2017
5Gonadotropin-Releasing Hormone (GnRH)FDA Link
12/2017 - 09/2010
4PlatinumIBA
01/2022 - 05/2017
4DNA (Deoxyribonucleic Acid)IBA
12/2021 - 12/2012
4Monoclonal AntibodiesIBA
11/2021 - 01/2018
4Proteins (Proteins, Gene)FDA Link
12/2020 - 02/2015
3Carboplatin (JM8)FDA LinkGeneric
12/2021 - 12/2018
3osimertinibIBA
06/2021 - 01/2021
3Pharmaceutical PreparationsIBA
01/2021 - 01/2019
3taxaneIBA
12/2017 - 03/2012
3LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA
12/2017 - 06/2011
2pralsetinibIBA
01/2022 - 01/2021
2agerafenibIBA
01/2022 - 01/2019
2AntigensIBA
12/2021 - 10/2016
2COVID-19 VaccinesIBA
05/2021 - 01/2021
2LigandsIBA
02/2021 - 10/2019
2VaccinesIBA
01/2021 - 01/2016
2Etoposide (VP 16)FDA LinkGeneric
01/2021 - 12/2018
2Anaplastic Lymphoma KinaseIBA
10/2020 - 03/2014
2NivolumabIBA
01/2020 - 11/2019
2Cetuximab (Erbitux)FDA Link
01/2019 - 05/2017
2CytokinesIBA
01/2019 - 01/2016
2ErbB Receptors (EGF Receptor)IBA
11/2018 - 03/2014
2rociletinibIBA
11/2018 - 03/2014
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2018 - 12/2017
2lysine(6)-doxorubicin LHRHIBA
12/2017 - 12/2014
1Circulating Tumor DNAIBA
01/2022
1Pemetrexed (MTA)FDA Link
01/2022
1Thyroid Nuclear Factor 1IBA
01/2022
1TropomyosinIBA
01/2022
1sintilimabIBA
01/2022
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
12/2021
1Heat-Shock Proteins (Heat-Shock Protein)IBA
12/2021
1SNX-5422IBA
12/2021
1Paclitaxel (Taxol)FDA LinkGeneric
12/2021
1Immunoconjugates (Immunoconjugate)IBA
11/2021
1tyrosine receptor (receptor, tyrosine)IBA
10/2021
1Immunoglobulin G (IgG)IBA
07/2021
1Programmed Cell Death 1 ReceptorIBA
07/2021
1Epidermal Growth Factor (EGF)IBA
02/2021
1ProdrugsIBA
01/2021
1AfatinibIBA
01/2021
1Dasatinib (BMS 354825)FDA Link
01/2021
1Neuregulin-1 (Neuregulin 1)IBA
01/2021
14- (2,6- dichlorobenzoylamino)- 1H- pyrazole- 3- carboxylic acid piperidin-4-ylamideIBA
12/2020
1(2,4- dihydroxy- 5- isopropylphenyl)- (5- (4- methylpiperazin- 1- ylmethyl)- 1,3- dihydroisoindol- 2- yl)methanoneIBA
12/2020
1CrizotinibIBA
10/2020
1alectinibIBA
10/2020
1Poly Adenosine Diphosphate RiboseIBA
10/2020
1Cytotoxins (Cytolysins)IBA
01/2020
1ORALIT (ORS)IBA
01/2020
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2020
1lutetium Lu 177 dotatateIBA
01/2020
1Somatostatin Receptors (Somatostatin Receptor)IBA
01/2020

Therapy/Procedure

32Therapeutics
01/2022 - 03/2010
17Drug Therapy (Chemotherapy)
01/2022 - 03/2010
15Immunotherapy
11/2022 - 01/2016
4Castration
12/2017 - 09/2010
1Patient Readmission
01/2022
1Critical Care (Surgical Intensive Care)
01/2020
1Ambulatory Care (Outpatient Care)
01/2020